Pharma and Translational Medicine Matching Genomic Solutions
Total genomic solutions offered by Eurofins Genomics
Many years of experience in the field of genetic analysis, crucial for the entire drug development and production process, make Eurofins Genomics a leading provider of total genomic solutions.
Benefit from a broad spectrum of services in the areas of analysis, research and development. Primary activities of Eurofins Genomics include services within molecular analyses of RNA and DNA from a wide range of species and specimens – always with a consultative approach.
Custom services and highly flexible laboratories dedicated to quality performance
Eurofins Genomics company is offering services specially tailored for the Pharmaceutical field, Companion Diagnostics and Translational Medicine. Pharmaceutical customers from 27 different countries across Europe, US and Asia confirm this.
With multiple specialized technological platforms Eurofins Genomics covers the entire value chain:
- Target identification
- Target validation
- Biomarker discovery and validation
- Preclinical development
- Clinical development: phases I, II and III
- Post approval
- Manufacturing
Applications – Optimised for pharmaceutical, biotech and translational medicine needs
- Various stabilisation and preparation methods like EDTA, PAXgene tubes, FF, FFPE
- High throughput nucleic extraction and aliquotation pipeline for biobanking purposes
- Sanger based genotyping
- Genetic stability testing (GLP sequencing)
- Resequencing
- RNA sequencing
- Exome sequencing
- Whole genome sequencing
- Metagenomics
- Adventitious virus testing via MPS
- Genetic stability testing under GLP
qPCR expression and genotyping
- Ready to use pharmacogenetics assays
- Assay development and execution
- High-throughput and flexibility
Microarrays for gene expression and genotyping
- New generation expression array
- Epigenetics: Methylation and miRNA
- Pharmacogenomics: DMET
- Oncology
- Cytogenetics
- GWAS and targeted arrays like the HLA Biobank array
Questions?
Partnering
Eurofins Genomics has been selected as one of a few strategic pharma-partners of Illumina in Europe.
Quality Assurance
